Doxycycline hyclate - QLT USA

Drug Profile

Doxycycline hyclate - QLT USA

Alternative Names: Atridox

Latest Information Update: 19 Aug 2016

Price : $50

At a glance

  • Originator QLT USA
  • Class Antibacterials; Collagenases; Skin disorder therapies; Tetracyclines
  • Mechanism of Action Protein 30S ribosomal subunit inhibitors
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity No

Highest Development Phases

  • Marketed Periodontal disorders

Most Recent Events

  • 05 Aug 2016 Meda has been acquired by Mylan
  • 01 Oct 2009 QLT USA has been acquired by Tolmar
  • 11 Apr 2008 CollaGenex Pharmaceuticals has been acquired by Galderma
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top